Tag: arteriotomy closure devices market insights

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for arteriotomy closure devices has been experiencing significant growth recently, driven by technological advances and increasing medical needs. As healthcare evolves, these devices are becoming more critical in improving patient outcomes during cardiovascular procedures. Below, we explore the current market size, key growth factors, segmentation, emerging trends, major players, and regional dynamics shaping this industry’s future.

Arteriotomy Closure Devices Market Size and Growth Outlook

The arteriotomy closure devices market has demonstrated strong expansion over recent years. It is projected to grow from $1.72 billion in 2025 to $1.84 billion in 2026, representing a compound annual growth rate (CAGR) of 6.9%. This growth during the historical period is primarily fueled by an increased number of catheter-based interventions, broader adoption of minimally invasive angiography techniques, rising rates of cardiovascular diseases, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services. Looking ahead, the market is expected to continue its upward trajectory, reaching $2.38 billion by 2030 at a CAGR of 6.7%. Key factors supporting this forecast include a rising demand for next-generation vascular closure systems, a growing focus on minimizing procedure-related complications, increasing outpatient vascular procedures, investments in bioresorbable materials, and wider adoption of advanced closure technologies. Notable trends shaping the future of this market include greater use of suture-based closure devices, preference for radial access closure solutions, enhanced utilization of bioabsorbable hemostatic materials, growth in minimally invasive vascular procedures, and an emphasis on accelerating patient recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

Cardiovascular Disease Trends Fueling Demand for Arteriotomy Closure Devices

A primary driver propelling the arteriotomy closure devices market is the increasing prevalence of cardiovascular diseases (CVDs). These disorders, which impact the heart and blood vessels, are becoming more widespread due to lifestyle factors such as poor diets, physical inactivity, obesity, and an aging global population. Arteriotomy closure devices play a crucial role in cardiovascular treatments by quickly and securely sealing arterial puncture sites, which helps reduce complications and speeds up recovery following interventions like angioplasties and catheterizations.

To illustrate, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that around 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. Projections suggest this number could increase by 1 million by 2030 and possibly rise by 2 million more by 2040. This rising patient population directly contributes to expanding demand in the arteriotomy closure devices market.

Detailed Segmentation of the Arteriotomy Closure Devices Market

This market is categorized into several segments to better understand revenue opportunities and product focus.

By Product Type:

– Active Closure Devices

– Passive Closure Devices

By Application:

– Femoral Arterial Access Procedures

– Radial Arterial Access Procedures

By End User:

– Hospitals

– Ambulatory Care Centers

– Other End Users

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Arteriotomy Closure Devices Market Global Footprint: Which Region Holds Market Leadership?

Further subcategories include:

Active Closure Devices, which comprise suture-based devices, staple-based devices, vascular closure devices containing collagen or hemostatic agents, and balloon-based devices.

Passive Closure Devices include compression devices, hemostatic patches or sponges, and vascular plugs.

Innovations and Technological Advancements Shaping Market Trends

Leading companies within the arteriotomy closure devices market are prioritizing innovation to increase procedural efficiency, improve clinical outcomes, and respond to the growing preference for minimally invasive vascular access solutions. One notable advancement is the development of mid-bore venous closure devices, designed to seal venous access points created by medium-sized catheters or sheaths, supporting hemostasis and faster patient recovery after interventions.

For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This new device is tailored for larger sheaths (10-12F, up to 15F outer diameter) used in procedures such as cryoablation. It features 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This addition complements Haemonetics’ offerings of small- and mid-bore vascular closure solutions, underscoring the company’s leadership in advanced closure technologies.

Key Players Driving the Arteriotomy Closure Devices Market Forward

Several prominent companies are shaping the direction of this market, including:

Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., and Vivasure Medical.

Geographical Market Outlook Highlighting Regional Leadership

In 2025, North America was the leading market for arteriotomy closure devices, holding the largest share globally. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast period. The market analysis includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of worldwide market trends and expansion opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Arteriotomy Closure Devices Market During 2026–2030?

The arteriotomy closure devices market has experienced robust expansion over recent years. It is projected to grow from $1.72 billion in 2025 to $1.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. The historical growth can be attributed to an increasing volume of catheter-based interventions, broader adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market size is projected to experience substantial expansion over the upcoming years. This market is set to reach $2.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. The anticipated growth during this period stems from several factors, including a heightened demand for advanced vascular closure solutions, an increased emphasis on minimizing procedure-related complications, the broadening scope of outpatient vascular procedures, rising investments in bioresorbable materials, and the wider integration of sophisticated closure technologies. Key trends anticipated during the forecast period involve a greater uptake of suture-based closure devices, a developing preference for radial access closure methods, increased utilization of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular interventions, and a stronger focus on achieving quicker patient recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

Which Drivers Are Advancing The Arteriotomy Closure Devices Market Growth?

The growing occurrence of cardiovascular diseases (CVDs) is projected to boost the expansion of the arteriotomy closure devices market. Cardiovascular diseases (CVDs) refer to a collection of conditions that affect the heart and blood vessels. The rise in the prevalence of cardiovascular diseases (CVDs) is largely attributable to increasing rates of risk factors such as unhealthy diets, lack of physical activity, and obesity, alongside an aging demographic. Arteriotomy closure devices play a crucial role in cardiovascular treatments by promptly and securely sealing arterial puncture sites, which helps reduce complications and improve patient recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, as per the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million individuals in the UK are currently living with heart and circulatory diseases, including 4 million men and 3.6 million women. By 2030, this figure might increase by 1 million, and by 2040, it could climb to 2 million more than the present numbers. Therefore, the escalating prevalence of cardiovascular diseases (CVDs) is fueling growth in the arteriotomy closure devices market.

What Are The Core Segment Classifications In The Arteriotomy Closure Devices Market?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

Which Trends Are Supporting The Evolution Of The Arteriotomy Closure Devices Market?

Leading companies within the arteriotomy closure devices market are prioritizing advancements in products to enhance procedural effectiveness, improve patient outcomes, and meet the growing demand for minimally invasive vascular access options. A mid-bore venous closure device is a specialized medical instrument crafted to seal venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and aiding patient recovery following interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare company, expanded its VASCADE portfolio with the introduction of the VASCADE MVP XL mid-bore venous closure device. This particular device, engineered for larger sheaths (10-12F, up to 15F outer diameter) utilized in operations such as cryoablation, integrates 58% more collagen and a larger collapsible disc to facilitate rapid hemostasis. This innovation, which complements Haemonetics’ existing array of small- and mid-bore vascular closure solutions, emphasizes the company’s leadership in sophisticated closure technologies.

Which Key Players Are Active In The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Access The Complete Arteriotomy Closure Devices Market Report:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Stands As The Largest Contributor To The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Arteriotomy Closure Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Arteriotomy Closure Devices Market During 2026–2030?

The arteriotomy closure devices market has experienced robust expansion over recent years. It is projected to grow from $1.72 billion in 2025 to $1.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. The historical growth can be attributed to an increasing volume of catheter-based interventions, broader adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market size is projected to experience substantial expansion over the upcoming years. This market is set to reach $2.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. The anticipated growth during this period stems from several factors, including a heightened demand for advanced vascular closure solutions, an increased emphasis on minimizing procedure-related complications, the broadening scope of outpatient vascular procedures, rising investments in bioresorbable materials, and the wider integration of sophisticated closure technologies. Key trends anticipated during the forecast period involve a greater uptake of suture-based closure devices, a developing preference for radial access closure methods, increased utilization of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular interventions, and a stronger focus on achieving quicker patient recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

Which Drivers Are Advancing The Arteriotomy Closure Devices Market Growth?

The growing occurrence of cardiovascular diseases (CVDs) is projected to boost the expansion of the arteriotomy closure devices market. Cardiovascular diseases (CVDs) refer to a collection of conditions that affect the heart and blood vessels. The rise in the prevalence of cardiovascular diseases (CVDs) is largely attributable to increasing rates of risk factors such as unhealthy diets, lack of physical activity, and obesity, alongside an aging demographic. Arteriotomy closure devices play a crucial role in cardiovascular treatments by promptly and securely sealing arterial puncture sites, which helps reduce complications and improve patient recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, as per the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million individuals in the UK are currently living with heart and circulatory diseases, including 4 million men and 3.6 million women. By 2030, this figure might increase by 1 million, and by 2040, it could climb to 2 million more than the present numbers. Therefore, the escalating prevalence of cardiovascular diseases (CVDs) is fueling growth in the arteriotomy closure devices market.

What Are The Core Segment Classifications In The Arteriotomy Closure Devices Market?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

Which Trends Are Supporting The Evolution Of The Arteriotomy Closure Devices Market?

Leading companies within the arteriotomy closure devices market are prioritizing advancements in products to enhance procedural effectiveness, improve patient outcomes, and meet the growing demand for minimally invasive vascular access options. A mid-bore venous closure device is a specialized medical instrument crafted to seal venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and aiding patient recovery following interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare company, expanded its VASCADE portfolio with the introduction of the VASCADE MVP XL mid-bore venous closure device. This particular device, engineered for larger sheaths (10-12F, up to 15F outer diameter) utilized in operations such as cryoablation, integrates 58% more collagen and a larger collapsible disc to facilitate rapid hemostasis. This innovation, which complements Haemonetics’ existing array of small- and mid-bore vascular closure solutions, emphasizes the company’s leadership in sophisticated closure technologies.

Which Key Players Are Active In The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Access The Complete Arteriotomy Closure Devices Market Report:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Stands As The Largest Contributor To The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Arteriotomy Closure Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Arteriotomy Closure Devices Market During 2026–2030?

The arteriotomy closure devices market size has demonstrated robust expansion recently. This market is projected to expand from $1.72 billion in 2025 to $1.84 billion in 2026, registering a compound annual growth rate (CAGR) of 6.9%. Factors contributing to its historical growth include an escalating volume of catheter-based interventions, increased adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the broader development of interventional cardiology services.

The arteriotomy closure devices market size is expected to experience significant growth in the coming years, with projections indicating it will reach $2.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This expansion during the forecast period is attributed to several factors, including the increasing demand for next-generation vascular closure solutions, a rising focus on reducing procedure-related complications, the broadening scope of outpatient vascular procedures, growing investments in bioresorbable materials, and the increasing adoption of advanced closure technologies. Prominent trends for this period encompass the increasing adoption of suture-based closure devices, a rising preference for radial access closure solutions, the growing use of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular procedures, and an enhanced focus on achieving faster patient recovery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Factors Are Contributing To The Growth Of The Arteriotomy Closure Devices Market?

The rising incidence of cardiovascular diseases (CVDs) is anticipated to propel the expansion of the arteriotomy closure devices market moving forward. Cardiovascular diseases (CVDs) are defined as a category of disorders impacting the heart and blood vessels. This escalation in CVD prevalence is largely due to increasing rates of risk factors such as unhealthy diets, physical inactivity, and obesity, coupled with an aging population. Arteriotomy closure devices are critical in cardiovascular treatments as they quickly and securely seal arterial puncture sites, thereby reducing complications and improving recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million individuals in the UK are currently affected by heart and circulatory diseases, consisting of 4 million men and 3.6 million women. By 2030, this figure could increase by 1 million, and by 2040, it may rise to 2 million more than the current statistics. Thus, the growing prevalence of cardiovascular diseases (CVDs) is stimulating growth in the arteriotomy closure devices market.

Which Segment Types Are Examined In The Arteriotomy Closure Devices Market Segment Study?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Trends Are Shaping The Future Of The Arteriotomy Closure Devices Market?

Companies active in the arteriotomy closure devices market are prioritizing product innovation to improve procedural efficiency, enhance patient outcomes, and meet the growing demand for minimally invasive vascular access solutions. A mid-bore venous closure device serves as a medical instrument engineered to close venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and aiding in patient recovery after interventional procedures. For instance, in June 2024, Haemonetics Corp, a US-based healthcare company, expanded its VASCADE portfolio with the introduction of the VASCADE MVP XL mid-bore venous closure device. This device, specifically designed for larger sheaths (10-12F, up to 15F outer diameter) utilized in procedures like cryoablation, incorporates 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This advancement complements Haemonetics’ existing range of small- and mid-bore vascular closure solutions, affirming the company’s leadership in advanced closure technologies.

Which Players Are Part Of The Competitive Landscape Of The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Get The Full Arteriotomy Closure Devices Market Report:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Where Is The Arteriotomy Closure Devices Market Primarily Concentrated By Region?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Arteriotomy Closure Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Arteriotomy Closure Devices Market Evolve From 2026 To 2030?

The arteriotomy closure devices market size has seen robust growth in recent years. Its value is anticipated to rise from $1.72 billion in 2025 to $1.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this expansion has been driven by an increasing volume of catheter-based interventions, broader adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $2.38 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.7%. This growth over the forecast period can be attributed to an escalating demand for next-generation vascular closure solutions, a heightened emphasis on mitigating procedure-related complications, the expansion of outpatient vascular procedures, increasing investments in bioresorbable materials, and the growing adoption of advanced closure technologies. Major trends during this period are expected to include the increasing adoption of suture-based closure devices, a rising preference for radial access closure solutions, the growing use of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular procedures, and an enhanced focus on faster patient recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Key Drivers Are Influencing The Growth Of The Arteriotomy Closure Devices Market?

The anticipated rise in cardiovascular diseases (CVDs) is projected to drive the expansion of the arteriotomy closure devices market in the future. CVDs encompass a range of conditions impacting the heart and blood vessels. This growing prevalence of cardiovascular diseases (CVDs) is primarily attributed to an increase in risk factors like poor diets, sedentary lifestyles, and obesity, in addition to an aging demographic. Crucial for cardiovascular interventions, arteriotomy closure devices facilitate rapid and secure sealing of arterial access points, thereby minimizing adverse events and enhancing post-procedure recovery from processes such as angioplasties and catheterizations. For example, data from September 2024, provided by the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that about 7.6 million people in the UK are currently living with heart and circulatory conditions, consisting of 4 million men and 3.6 million women. Projections suggest this figure could climb by 1 million by 2030, and potentially by 2 million above current levels by 2040. Consequently, the expanding prevalence of cardiovascular diseases (CVDs) is fueling the expansion of the arteriotomy closure devices market.

Which Segment Areas Are Covered In The Arteriotomy Closure Devices Market Analysis?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Key Developments And Trends Are Impacting The Arteriotomy Closure Devices Market?

Leading companies within the arteriotomy closure devices market are actively pursuing product innovation to elevate procedural efficiency, improve patient outcomes, and address the increasing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is defined as a medical instrument designed to seal venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and facilitating patient recovery subsequent to interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare company, enhanced its VASCADE portfolio by introducing the VASCADE MVP XL mid-bore venous closure device. This specific device, developed for larger sheaths (10-12F, up to 15F outer diameter) utilized in procedures like cryoablation, includes 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This innovation further complements Haemonetics’ existing array of small- and mid-bore vascular closure solutions, emphasizing the company’s leadership in advanced closure technologies.

Which Global Companies Are Actively Competing In The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Read the full arteriotomy closure devices market report here:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arteriotomy Closure Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Arteriotomy Closure Devices Market Evolve From 2026 To 2030?

The arteriotomy closure devices market size has seen robust growth in recent years. Its value is anticipated to rise from $1.72 billion in 2025 to $1.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this expansion has been driven by an increasing volume of catheter-based interventions, broader adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $2.38 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.7%. This growth over the forecast period can be attributed to an escalating demand for next-generation vascular closure solutions, a heightened emphasis on mitigating procedure-related complications, the expansion of outpatient vascular procedures, increasing investments in bioresorbable materials, and the growing adoption of advanced closure technologies. Major trends during this period are expected to include the increasing adoption of suture-based closure devices, a rising preference for radial access closure solutions, the growing use of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular procedures, and an enhanced focus on faster patient recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Key Drivers Are Influencing The Growth Of The Arteriotomy Closure Devices Market?

The anticipated rise in cardiovascular diseases (CVDs) is projected to drive the expansion of the arteriotomy closure devices market in the future. CVDs encompass a range of conditions impacting the heart and blood vessels. This growing prevalence of cardiovascular diseases (CVDs) is primarily attributed to an increase in risk factors like poor diets, sedentary lifestyles, and obesity, in addition to an aging demographic. Crucial for cardiovascular interventions, arteriotomy closure devices facilitate rapid and secure sealing of arterial access points, thereby minimizing adverse events and enhancing post-procedure recovery from processes such as angioplasties and catheterizations. For example, data from September 2024, provided by the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that about 7.6 million people in the UK are currently living with heart and circulatory conditions, consisting of 4 million men and 3.6 million women. Projections suggest this figure could climb by 1 million by 2030, and potentially by 2 million above current levels by 2040. Consequently, the expanding prevalence of cardiovascular diseases (CVDs) is fueling the expansion of the arteriotomy closure devices market.

Which Segment Areas Are Covered In The Arteriotomy Closure Devices Market Analysis?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Key Developments And Trends Are Impacting The Arteriotomy Closure Devices Market?

Leading companies within the arteriotomy closure devices market are actively pursuing product innovation to elevate procedural efficiency, improve patient outcomes, and address the increasing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is defined as a medical instrument designed to seal venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and facilitating patient recovery subsequent to interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare company, enhanced its VASCADE portfolio by introducing the VASCADE MVP XL mid-bore venous closure device. This specific device, developed for larger sheaths (10-12F, up to 15F outer diameter) utilized in procedures like cryoablation, includes 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This innovation further complements Haemonetics’ existing array of small- and mid-bore vascular closure solutions, emphasizing the company’s leadership in advanced closure technologies.

Which Global Companies Are Actively Competing In The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Read the full arteriotomy closure devices market report here:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arteriotomy Closure Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Arteriotomy Closure Devices Market Evolve From 2026 To 2030?

The arteriotomy closure devices market size has seen robust growth in recent years. Its value is anticipated to rise from $1.72 billion in 2025 to $1.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this expansion has been driven by an increasing volume of catheter-based interventions, broader adoption of minimally invasive angiography procedures, a rise in cardiovascular disease prevalence, enhanced clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market is anticipated to experience robust growth in the upcoming years. It is projected to expand to $2.38 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.7%. This growth over the forecast period can be attributed to an escalating demand for next-generation vascular closure solutions, a heightened emphasis on mitigating procedure-related complications, the expansion of outpatient vascular procedures, increasing investments in bioresorbable materials, and the growing adoption of advanced closure technologies. Major trends during this period are expected to include the increasing adoption of suture-based closure devices, a rising preference for radial access closure solutions, the growing use of bioabsorbable hemostatic materials, the expansion of minimally invasive vascular procedures, and an enhanced focus on faster patient recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Key Drivers Are Influencing The Growth Of The Arteriotomy Closure Devices Market?

The anticipated rise in cardiovascular diseases (CVDs) is projected to drive the expansion of the arteriotomy closure devices market in the future. CVDs encompass a range of conditions impacting the heart and blood vessels. This growing prevalence of cardiovascular diseases (CVDs) is primarily attributed to an increase in risk factors like poor diets, sedentary lifestyles, and obesity, in addition to an aging demographic. Crucial for cardiovascular interventions, arteriotomy closure devices facilitate rapid and secure sealing of arterial access points, thereby minimizing adverse events and enhancing post-procedure recovery from processes such as angioplasties and catheterizations. For example, data from September 2024, provided by the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that about 7.6 million people in the UK are currently living with heart and circulatory conditions, consisting of 4 million men and 3.6 million women. Projections suggest this figure could climb by 1 million by 2030, and potentially by 2 million above current levels by 2040. Consequently, the expanding prevalence of cardiovascular diseases (CVDs) is fueling the expansion of the arteriotomy closure devices market.

Which Segment Areas Are Covered In The Arteriotomy Closure Devices Market Analysis?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Key Developments And Trends Are Impacting The Arteriotomy Closure Devices Market?

Leading companies within the arteriotomy closure devices market are actively pursuing product innovation to elevate procedural efficiency, improve patient outcomes, and address the increasing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is defined as a medical instrument designed to seal venous access sites created by mid-sized catheters or sheaths, thereby promoting hemostasis and facilitating patient recovery subsequent to interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare company, enhanced its VASCADE portfolio by introducing the VASCADE MVP XL mid-bore venous closure device. This specific device, developed for larger sheaths (10-12F, up to 15F outer diameter) utilized in procedures like cryoablation, includes 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. This innovation further complements Haemonetics’ existing array of small- and mid-bore vascular closure solutions, emphasizing the company’s leadership in advanced closure technologies.

Which Global Companies Are Actively Competing In The Arteriotomy Closure Devices Market?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Read the full arteriotomy closure devices market report here:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Arteriotomy Closure Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the collaborative robotic joint module market from 2026–2035 with trusted insights from The Business Research Company

How much is the Arteriotomy Closure Devices Market valued at in 2026, and what valuation is forecast for 2030?

The arteriotomy closure devices market has experienced significant growth in recent years. It is projected to expand from $1.72 billion in 2025 to $1.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The market’s expansion in the historic period is attributable to an increasing volume of catheter-based interventions, wider adoption of minimally invasive angiography procedures, growth in cardiovascular disease prevalence, improved clinical acceptance of closure devices, and the expansion of interventional cardiology services.

The arteriotomy closure devices market is projected to experience substantial expansion in the coming years, with its size expected to reach $2.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is primarily due to several factors, including the escalating demand for innovative vascular closure solutions, a heightened emphasis on minimizing complications associated with procedures, the expansion of outpatient vascular interventions, increasing investments in bioresorbable materials, and a wider embrace of sophisticated closure technologies. Key trends expected over the forecast period encompass a greater uptake of suture-based closure devices, a growing inclination towards radial access closure solutions, an expanded application of bioabsorbable hemostatic materials, the proliferation of minimally invasive vascular procedures, and a stronger focus on accelerating patient recovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Drivers Are Influencing The Growth Of The Arteriotomy Closure Devices Market?

The rising occurrence of cardiovascular diseases (CVDs) is projected to boost the growth of the arteriotomy closure devices market. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, and their increasing prevalence is primarily driven by escalating risk factors such as unhealthy eating patterns, lack of physical activity, and obesity, coupled with an aging demographic. Arteriotomy closure devices are vital in cardiovascular procedures, as they enable the rapid and secure sealing of arterial puncture sites, thus reducing complications and enhancing patient recovery following interventions like angioplasties and catheterizations. For instance, data from September 2024 released by the British Heart Foundation, a UK-based cardiovascular research charity, indicates that around 7.6 million individuals in the UK are presently afflicted by heart and circulatory diseases, consisting of 4 million men and 3.6 million women. This total could climb by 1 million by 2030 and potentially reach 2 million more than current numbers by 2040. Therefore, the higher prevalence of cardiovascular diseases (CVDs) is a key driver for the arteriotomy closure devices market.

What Segments Are Included Within The Arteriotomy Closure Devices Market?

The arteriotomy closure devices market covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Industry Trends Are Transforming The Arteriotomy Closure Devices Market?

Leading companies in the arteriotomy closure devices market are concentrating on product innovation to improve procedural efficiency, enhance patient outcomes, and satisfy the increasing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a specialized medical tool crafted to seal venous access points made by medium-sized catheters or sheaths, thereby promoting hemostasis and aiding patient recovery after interventional procedures. For illustration, in June 2024, Haemonetics Corp, a healthcare company based in the US, expanded its VASCADE range with the introduction of the VASCADE MVP XL mid-bore venous closure device. This device, specifically developed for use with larger sheaths (10-12F, up to 15F outer diameter) in procedures like cryoablation, features 58% more collagen and a bigger collapsible disc to facilitate quick hemostasis. This innovation, which supplements Haemonetics’ existing selection of small- and mid-bore vascular closure products, emphasizes the company’s prominent position in advanced closure technologies.

Who Are The Top-Performing Companies In The Arteriotomy Closure Devices Market In Recent Years?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Arteriotomy Closure Devices Market?

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Arteriotomy Closure Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2026, By The Business Research Company

Heart Defect Closure Device Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Vascular Access Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-access-devices-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Arteriotomy Closure Devices Market By 2029?

The market for arteriotomy closure devices has experienced robust expansion recently, projected to increase its value from $1.61 billion recorded in 2024 to $1.72 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.6%. This historical upward trend is fundamentally driven by several key factors, namely the surge in minimally invasive surgical procedures, a higher incidence rate of cardiovascular ailments, the increased utilization of catheterization techniques, the demographic shift toward an older population base, and a persistent market requirement for faster patient recovery.

Anticipated for the near future is substantial expansion within the market for arteriotomy closure devices, projecting a valuation of $2.24 billion by 2029, fueled by a consistent compound annual growth rate of 6.8%; this upward trajectory in the coming years is fundamentally driven by the increasing prevalence of atherosclerosis, the escalating volume of coronary artery disease cases, heightened emphasis on ensuring both patient security and ease during procedures, the expansion of medical facilities in developing nations, and a greater need for facilities like ambulatory surgical centers, concurrently, key developments shaping this period involve a shift towards less invasive surgical approaches, the incorporation of materials that naturally dissolve, the integration of automated systems into the closure process, efforts to enhance how effectively procedures are carried out, and the development of novel closure apparatus designed for punctures in larger arteries.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

Which Industry Drivers Are Expected To Accelerate The Arteriotomy Closure Devices Market From 2025 To 2029?

The escalating incidence of heart and blood vessel disorders, collectively termed cardiovascular diseases (CVDs), is anticipated to fuel the expansion of the market for arteriotomy closure devices. This growing burden of CVDs stems primarily from escalating levels of associated risk elements such as poor eating habits, sedentary lifestyles, and increased obesity rates, compounded by an older demographic structure. Arteriotomy closure devices play a crucial role in cardiac interventions by rapidly and reliably sealing arterial access points, thereby minimizing post-procedural issues following interventions like catheterizations and angioplasties, and facilitating faster patient recovery. To illustrate this impact, data shared in September 2024 by the British Heart Foundation, a prominent UK charity dedicated to heart health research, indicated that roughly 7.6 million people in the United Kingdom currently grapple with heart and circulatory ailments, split between 4 million males and 3.6 million females; projections suggest an additional million cases by 2030 and two million more than today’s count by 2040. Consequently, the rising tide of cardiovascular disease prevalence directly underpins the upward trajectory observed in the arteriotomy closure devices market.

What Are The Emerging Segments Gaining Attention In The Arteriotomy Closure Devices Market?

The arteriotomy closure devicesmarket covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

Which Key Trends Are Expected To Influence The Arteriotomy Closure Devices Market In The Coming Years?

Leading enterprises within the arteriotomy closure device sector are concentrating their efforts on pioneering novel products aimed at boosting procedural swiftness, elevating patient recovery results, and satisfying the growing need for surgical approaches that involve less invasion into blood vessels. A venous closure apparatus specifically engineered for mid-bore access points serves the purpose of securing the openings made by catheters or sheaths of moderate size, thereby facilitating blood clotting and assisting individuals in recovering following interventional medical treatments. To illustrate, in June of 2024, Haemonetics Corp, a healthcare entity situated in the United States, bolstered its VASCADE product line by introducing the VASCADE MVP XL, a closure device intended for mid-bore venous access. This newly released instrument, which accommodates larger sheaths ranging from 10 to 12 French (with an outer diameter capacity up to 15 French) often employed in procedures such as cryoablation, features a composition containing 58 percent additional collagen and a bigger expandable disc to ensure the swift cessation of bleeding. This advancement is a testament to Haemonetics’ prominent position in developing sophisticated closure technology, effectively broadening their existing suite of closure systems for both small and mid-sized vascular access needs.

Who Are The Top Performing Companies In The Arteriotomy Closure Devices Market In Recent Years?

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

What Regional Growth Trends Are Shaping The Arteriotomy Closure Devices Market Outlook?

North America was the largest region in the arteriotomy closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Arteriotomy Closure Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Browse Through More Reports Similar to the Global Arteriotomy Closure Devices Market 2025, By The Business Research Company

Coronary Artery Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Peripheral Artery Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Coronary Artery Bypass Graft Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Arteriotomy Closure Devices Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there has been a notable expansion in the arteriotomy closure devices market size. An upswing from $1.61 billion in 2024 to $1.72 billion in 2025, which indicates a compound annual growth rate (CAGR) of 6.6%, is anticipated. The growth in the past years can be credited to factors such as the rise in minimally invasive surgeries, increased occurrence of cardiovascular diseases, heightened use of catheterization procedures, an upscale in the aging population, and the need for faster recovery periods.

Expectations are high for the arteriotomy closure devices market as strong growth is anticipated in the coming years, with projected estimates reaching $2.24 billion by 2029. This growth, showing a compound annual growth rate (CAGR) of 6.8%, can be credited to several factors. These include an increasing occurrence of atherosclerosis, the upswing in coronary artery diseases, a greater emphasis on patient safety and comfort, the expansion of healthcare infrastructure in emerging economies, and a rising need for ambulatory surgical centres. During the forecast period, key trends to watch include the growing preference for minimally invasive techniques, the use of bioresorbable materials, the incorporation of automation in closure procedures, augmented procedural efficiency, and innovative approaches to closure devices for major arterial punctures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20712&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Arteriotomy Closure Devices Market?

The surge in cardiovascular diseases (CVDs) is anticipated to boost the arteriotomy closure devices market’s expansion. CVDs are a collection of disorders impacting the heart and blood vessels. This escalation is primarily attributed to the growing prevalence of risk factors such as unhealthy eating habits, lack of physical activity, obesity, alongside an aging populace. Arteriotomy closure devices are vital in cardiovascular treatments as they effectively seal arterial punctures, thereby reducing complications and enhancing recovery post procedures like angioplasties and catheterizations. For example, as reported by the British Heart Foundation, a cardiovascular research charity based in the UK, roughly 7.6 million individuals, 4 million men and 3.6 million women have heart and circulatory diseases in the UK as of September 2024. By 2030, this figure could rise by 1 million, and by 2040, it may increase by an additional 2 million from today’s statistics. Consequently, the surge in cardiovascular diseases (CVDs) prevalence fosters the arteriotomy closure devices market’s growth.

Which Key Market Segments Comprise the Arteriotomy Closure Devices Market and Drive Its Revenue Growth?

The arteriotomy closure devicesmarket covered in this report is segmented –

1) By Product: Active Closure Devices, Passive Closure Devices

2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures

3) By End User: Hospitals, Ambulatory Care Centers, Other End Users

Subsegments:

1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices

2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20712&type=smp

Which Areas Are Leading Regions in the Arteriotomy Closure Devices Market Expansion Across the Globe?

North America was the largest region in the arteriotomy closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theArteriotomy Closure Devices Market Direction?

Leading businesses in the arteriotomy closure devices market are prioritizing advancements in product technology to boost procedural effectiveness, enhance patient results, and cater to the increasing need for minimally invasive solutions for vascular access. A mid-bore venous closure device is a medical instrument engineered to seal vascular access points established by medium-sized catheters or sheaths, thus promoting blood clotting and aiding patient recovery post-interventional processes. For example, in June 2024, Haemonetics Corp, a healthcare firm based in the US, broadened its VASCADE line by introducing the VASCADE MVP XL mid-bore venous closure device. This device is specifically created for larger sheaths (10-12F, up to 15F outer diameter) applied in procedures such as cryoablation. It integrates 58% additional collagen and a larger foldable disc to attain rapid blood clotting. This development, supplementing Haemonetics’ existing collection of small- and mid-bore closure solutions for the vascular system, highlights the firm’s dominance in cutting-edge closure technologies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/arteriotomy-closure-devices-global-market-report

How Is the Arteriotomy Closure Devices Market Conceptually Defined?

An arteriotomy closure device (ACD) is a medical device designed to seal the puncture site in an artery following procedures such as catheterization or angiography. It facilitates hemostasis by closing the arterial opening, reducing bleeding risks, and promoting faster recovery compared to manual compression methods. ACDs are commonly used in minimally invasive vascular procedures to enhance patient safety and procedural efficiency.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20712

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model